A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations

NCT02596100 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Portola Pharmaceuticals